Zobrazeno 1 - 10
of 20
pro vyhledávání: '"van Tinteren, Harm"'
Autor:
Brivio E; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Pennesi E; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Willemse ME; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Jiang Y; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Tinteren HDR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Beverloo BH; Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands., den Boer ML; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Rammeloo LAJ; Department of Pediatric Cardiology, Amsterdam UMC, Emma Children's Hospital, Amsterdam, the Netherlands., Hudson C; Hematologics Inc, Seattle, WA., Heerema N; Nationwide Children's Hospital, Columbus, OH., Kowalski K; Pfizer Inc, New York, NY., Zhao H; Pfizer Inc, New York, NY., Kuttschreuter L; Pfizer Inc, New York, NY., Bautista Sirvent FJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pediatric Oncology and Hematology Department, Hospital Niño Jesús, Madrid, Spain., Bukowinski A; Pediatric Hematology and Oncology Alabama, University of Alabama at Birmingham, Birmingham, AL., Rizzari C; Department of Pediatrics, University of Milano-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Pollard J; Dana-Farber/Harvard Cancer Center, Boston, MA., Murillo-Sanjuán L; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Kutny M; Children's Hospital of Alabama, Birmingham, AB., Zarnegar-Lumley S; Vanderbilt University, Nashville, TN., Redell M; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Cooper S; Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD., Bertrand Y; CHU Lyon, Hospices Civils de Lyon, Lyon, France., Petit A; Hôpital Armand Trousseau, Paris, France., Krystal J; The Steven and Alexandra Cohen Children's Medical Center of New York, New York, NY., Metzler M; Universitätsklinikum Erlangen, Erlangen, Germany., Lancaster D; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Bourquin JP; University Children's Hospital, Zürich, Switzerland., Motwani J; Birmingham Children's Hospital, Birmingham, United Kingdom., van der Sluis IM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Locatelli F; IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Roth ME; University of Texas MD Anderson Cancer Center, Houston, TX., Hijiya N; Columbia University Irving Medical Center, New York, NY., Zwaan CM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 01; Vol. 42 (7), pp. 821-831. Date of Electronic Publication: 2023 Nov 30.
Autor:
Daenen LG; Department of Medical Oncology, University Medical Center Utrecht, the Netherlands., Cirkel GA; Department of Medical Oncology, University Medical Center Utrecht, the Netherlands., Houthuijzen JM; Department of Molecular Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Gerrits J; Department of Medical Genetics, University Medical Center Utrecht, the Netherlands., Oosterom I; Department of Medical Oncology, University Medical Center Utrecht, the Netherlands., Roodhart JM; Department of Medical Oncology, University Medical Center Utrecht, the Netherlands., van Tinteren H; Department of Biometrics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Ishihara K; National Research Institute of Fisheries Science Kanazawaku, Yokohama, Japan., Huitema AD; Department of Pharmacy and Pharmacology, the Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, the Netherlands., Verhoeven-Duif NM; Department of Medical Genetics, University Medical Center Utrecht, the Netherlands., Voest EE; Department of Medical Oncology, University Medical Center Utrecht, the Netherlands2Department of Molecular Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2015 Jun; Vol. 1 (3), pp. 350-8.
Autor:
Badrising S; Department of Oncology, Tergooi Hospital, Blaricum, the Netherlands., van der Noort V, van Oort IM, van den Berg HP, Los M, Hamberg P, Coenen JL, van den Eertwegh AJ, de Jong IJ, Kerver ED, van Tinteren H, Bergman AM
Publikováno v:
Cancer [Cancer] 2014 Apr 01; Vol. 120 (7), pp. 968-75. Date of Electronic Publication: 2013 Dec 30.
Autor:
Mertens LS; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S
Publikováno v:
The Journal of urology [J Urol] 2012 Oct; Vol. 188 (4), pp. 1108-13. Date of Electronic Publication: 2012 Aug 15.
Autor:
de Boer JP; Department of Medical Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. j.d.boer@nki.nl, Raderer M, van Tinteren H, Aleman BM, Boot H, de Jong D
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2011 Dec; Vol. 52 (12), pp. 2262-9. Date of Electronic Publication: 2011 Sep 29.
Autor:
Bex A; Department of Urology, Cancer Institute, Amsterdam, the Netherlands. a.bex@nki.nl, Blank C, Meinhardt W, van Tinteren H, Horenblas S, Haanen J
Publikováno v:
Urology [Urology] 2011 Oct; Vol. 78 (4), pp. 832-7. Date of Electronic Publication: 2011 Jul 29.
Autor:
Quarles van Ufford HM; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. h.m.e.quarlesvanufford@umcutrecht.nl, van Tinteren H, Stroobants SG, Riphagen II, Hoekstra OS
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2010 Oct; Vol. 51 (10), pp. 1507-16. Date of Electronic Publication: 2010 Sep 16.
Autor:
Straver ME; Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. m.straver@nki.nl, Glas AM, Hannemann J, Wesseling J, van de Vijver MJ, Rutgers EJ, Vrancken Peeters MJ, van Tinteren H, Van't Veer LJ, Rodenhuis S
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2010 Feb; Vol. 119 (3), pp. 551-8. Date of Electronic Publication: 2009 Feb 13.
Autor:
Hoebers FJ; Department of Radiotherapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, The Netherlands, f.hoebers@nki.nl, Kartachova M, de Bois J, van den Brekel MW, van Tinteren H, van Herk M, Rasch CR, Valdés Olmos RA, Verheij M
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2008 Mar; Vol. 35 (3), pp. 509-18. Date of Electronic Publication: 2007 Nov 10.
Autor:
Bueno-de-Mesquita JM; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Harten WH; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., van 't Veer LJ; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Agendia, Amsterdam, Netherlands., van Dam FS; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Karsenberg K; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Douma KF; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Tinteren H; Biometric Department, Netherlands Cancer Institute, Amsterdam, Netherlands., Peterse JL; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Wesseling J; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Wu TS; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Atsma D; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Rutgers EJ; Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Brink G; Agendia, Amsterdam, Netherlands., Floore AN; Agendia, Amsterdam, Netherlands., Glas AM; Agendia, Amsterdam, Netherlands., Roumen RM; Department of Surgery, Maxima Medical Centre, Eindhoven, Netherlands., Bellot FE; Department of Pathology, Spaarne Hospital, Hoofddorp, Netherlands., van Krimpen C; Department of Pathology, Reinier de Graaf Hospital, Delft, Netherlands., Rodenhuis S; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van de Vijver MJ; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, Academic Medical Centre, Amsterdam, Netherlands., Linn SC; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: s.linn@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2007 Dec; Vol. 8 (12), pp. 1079-1087. Date of Electronic Publication: 2007 Nov 26.